Cost of risdiplam?

Risdiplam (brand Evrysdi) is a high-cost SMA therapy, and prices vary a lot by country, insurer, and patient assistance programs.

- United States: List price is roughly $340,000–$360,000 per year. That’s about $28,000–$30,000 per month before any discounts, rebates, or insurance adjustments. Your actual out-of-pocket will depend on your insurance plan and any patient assistance programs.

- Other countries: Prices are typically negotiated with national payers and can be lower than the US list price, but exact amounts aren’t always publicly published. Availability of patient support programs also varies by country.

If you’d like, tell me the country or region you’re interested in (and whether you want US pricing or international pricing), and I can provide more specific ballpark figures and any known patient assistance options.